BBOT BridgeBio Oncology Therapeutics, Inc.
Company Analysis
Latest News
🟢 BridgeBio Oncology Therapeutics is trading 5% up despite broader market weakness
BridgeBio Oncology Therapeutics is trading at $2.82, up 5.22%, with no clear company-specific catalyst identified for its October 22, 2026 gain. - Its latest...
🔴 BridgeBio Oncology Therapeutics is trading 5% down
BridgeBio Oncology Therapeutics is trading 5.09% lower at $2.71, and available information does not establish a reason for the move. - The provided premarket...
🔴 BridgeBio Oncology Therapeutics is trading 8.42% down in pre-market as biotech ETF XBI falls
BridgeBio Oncology Therapeutics is trading at $2.61, down -8.42% in pre-market, with biotech-sector weakness the likeliest explanation. - Biotech ETF XBI was...
🔴 BridgeBio Oncology Therapeutics is trading 6.3% down with no clear company-specific catalyst identified
BridgeBio Oncology Therapeutics is trading 6.3% down at $3.06; no clear company-specific announcement explaining the October 13 decline was identified. - The...
🟢 BridgeBio Oncology Therapeutics is trading 9% up in pre-market — catalyst remains unclear
BridgeBio Oncology Therapeutics is trading 8.76% higher at $3.60 in pre-market on October 12; the reason for the move remains unclear. - The stock closed at...